Evidence map›Paper›PMID 24349376›Full record

ArticlePloS one2013

Prognostic value of discs large homolog 7 transcript levels in prostate cancer.

Christian R Gomez, Farhad Kosari, Jan-Marie Munz, Claire A Schreiber, Gaylord J Knutson, Cristiane M Ida, Abdelouahid El Khattouti, R Jeffrey Karnes, John C Cheville, George Vasmatzis and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prognostic value of DLGAP5 in colorectal cancer.International journal of colorectal disease · 2019
    Article
  11. Article
  12. ZWINT is the next potential target for lung cancer therapy.Journal of cancer research and clinical oncology · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Christian R GomezStem Cell Laboratory, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America ; Division of Preventive and Occupational Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Farhad KosariDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Jan-Marie MunzDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Claire A SchreiberStem Cell Laboratory, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America.
Gaylord J KnutsonStem Cell Laboratory, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America.
Cristiane M IdaDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Abdelouahid El KhattoutiUniversity of Mississippi Medical Center, Jackson, Mississippi, United States of America.
R Jeffrey KarnesDepartment of Urology, Mayo Clinic, Rochester, Minnesota, United States of America.
John C ChevilleDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
George VasmatzisDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Stanimir Vuk-PavlovićStem Cell Laboratory, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America ; Division of Preventive and Occupational Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Mayo Clinic · USUniversity of Mississippi Medical Center · US

Funding

Utility of serum and Tissue Biomarkers for Predicting Response to Androgen DeprivP50CA091956 · NCI · MAYO CLINIC ROCHESTER · PI TINDALL, DONALD J. · 2001 to 2010
$23.4M
NCI NIH HHS P50 CA091956NCI NIH HHS SPORE 5P50CA091956
6 · The paper itself

Abstract

Hypoxia has been associated with malignant progression, metastasis and resistance to therapy. Hence, we studied expression of hypoxia-regulated genes in 100 prostate cancer (CaP) bulk tissues and 71 adjacent benign tissues. We found 24 transcripts significantly overexpressed (p ≤ 0.02). Importantly, higher transcript levels of disc large (drosophila) homolog-associated protein 5 (DLGAP5)/discs large homolog 7 (DLG7)/hepatoma up-regulated protein (HURP), hyaluronan-mediated motility receptor (HMMR) and cyclin B1 (CCNB1) were associated with higher Gleason score and more advanced systemic progression. Since the products of HMMR and CCNB1 have been identified recently as molecular markers of CaP progression, we postulated that DLG7 has prognostic value too. To test this hypothesis, we measured transcript levels for DLG7 in a 150-pair case-control cohort. The cases (progression to systemic disease within six years of surgery) and controls (no progression within eight years) were matched for clinical and pathologic prognostic variables, including grade, stage, and preoperative serum levels of PSA. The overall prognostic ability of DLG7, as tested in receiver operating characteristic analysis was of 0.74 (95% CI, 0.68 to 0.8). Overall, our data indicate that expression of DLG7, a hypoxia-controlled gene, holds prognostic potential in high-risk CaP; this also demonstrates that variation of oxygen tension may constitute a tool for identification of novel biomarkers for CaP.

Indexed as

Gene Expression Regulation, NeoplasticTranscription, GeneticCase-Control StudiesFollow-Up StudiesGene Expression ProfilingHumansHypoxiaMaleNeoplasm GradingNeoplasm ProteinsNeoplasm StagingPrognosisProstatic NeoplasmsROC CurveDLGAP5 protein, humanNeoplasm Proteins

Identifiers

PMID24349376
PMCPMC3857287
OpenAlexW2074670346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.